OnKure Therapeutics, Inc. (OKUR) Stock Overview
Explore OnKure Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
OnKure Therapeutics, Inc. (OKUR)
Key Financials
Key Financials
Market Cap
123.9M
P/E Ratio
-0.87
EPS (TTM)
$-3.50
ROE
-0.49%
OKUR Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of OnKure Therapeutics, Inc. (NASDAQ: OKUR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, OnKure Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of OKUR on the NASDAQ shows an RSI of 30.28, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind OnKure Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.87 and a market capitalization of 123.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of OKUR on the NASDAQ.